Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to investigate the efficacy and safety of autologous cord blood transfusions in very-low-birth-weight premature infants, and to evaluate the developmental outcomes of the infants who received autologous transfusions.


Clinical Trial Description

Blood transfusions have many risks including transfusion reactions and infections. Cord blood is accepted as an alternative method for red cell transfusions in low-birth weight (LBW) premature newborns. However, experience and scientific evidence concerning in-vivo efficacy and safety of red blood cell (RBC) concentrates derived from cord blood in very LBW premature newborns is still insufficient.

A total of 50 umbilical cord blood (UCB) collected from infants born before 32 weeks' gestational age and processed into autologous RBC products. Infants requiring blood transfusion were randomly assigned to an autologous or allogeneic product. Two randomized groups were compared on the 14th, 28th, 35th days and >35th days with respect to hemoglobin levels, transfusion numbers, transfusion and phlebotomy volumes, and hemoglobin, reticulocyte counts and erythropoietin levels in the postconceptional 36th and 40th weeks' gestation, and hemoglobin levels at postnatal 6-months age. All transfused infants were developmentally assessed by the end of the postnatal first year. ;


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT02101086
Study type Interventional
Source Ankara University
Contact
Status Completed
Phase N/A
Start date March 2009
Completion date January 2012

See also
  Status Clinical Trial Phase
Completed NCT00167388 - The Effect of Blood Transfusion on Blood Flow to the Intestines of Premature Infants Phase 1
Completed NCT01735578 - Splanchnic Tissue Oxygenation During Enteral Feedings in Anemic Premature Infants at Risk for Necrotizing Enterocolitis N/A
Recruiting NCT04497012 - Iron Supplementation and Intestinal Health Phase 4
Completed NCT01539356 - Hepcidin Levels in Preterm Infants N/A
Recruiting NCT04509375 - Near-Infrared Spectroscopy and Cranial Doppler in Premature Newborns With Anemia
Terminated NCT01735552 - Transfusion-related Inflammatory Cytokine and Neutrophil Extracellular Trap Quantification in Neonates N/A
Completed NCT00458068 - Early Versus Late Enteral Iron in Infants Less Than 1301 Grams N/A
Not yet recruiting NCT06220461 - Folic Acid Supplementation to Reduce Anemia in Extremely Preterm Infants N/A
Completed NCT01393496 - Effects of Transfusion Thresholds on Neurocognitive Outcome of Extremely Low Birth Weight Infants Phase 4
Withdrawn NCT01121328 - Autologous Umbilical Cord Blood Transfusion for Preterm Neonates Phase 1
Completed NCT00182390 - Premature Infants in Need of Transfusion (PINT) Phase 3
Completed NCT00457990 - Neurodevelopment After Early Iron Supplementation N/A